Strategies for improving documentation and reducing medication errors related to drug allergy

Villamañán, Elena; Larrubia, Yolanda; Ruano, Margarita; Herrero, Alicia; Álvarez-Sala, R.

doi:10.1007/s11096-011-9578-y

Cited by 6 publications

(6 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The purpose of this study was to provide actionable knowledge for the development and promotion of PHRs using an ADR interventionist method. Using this method, we built a DAC based on a collaborative project related to a ground medical problem (lack of accessibility, completeness, accuracy, and traceability of allergy information) identified in the medical literature (Chiriac et al, 2019;Khalil et al, 2011;Villamañán et al, 2011).…”

Section: Discussionmentioning

confidence: 99%

“…A specific kind of PHR related to a specific context is the digital allergy card (DAC). Because the current drug allergy information process is not optimal for the transmission of the right information at the right time, the European Academy of Allergology and Clinical Immunology (EAACI) has proposed the implementation of allergy apps (Brockow et al, 2016;Khalil et al, 2011;Villamañán et al, 2011). Therefore, the goal of a DAC is to ensure patient safety by making allergy information available to make the optimal therapeutic decision.…”

Section: Introductionmentioning

confidence: 99%

“…Therefore, the goal of a DAC is to ensure patient safety by making allergy information available to make the optimal therapeutic decision. Indeed, problems with allergy information can cause serious harm, especially drug allergies, which require special attention from physicians-mostly family practitioners-when they write a prescription (Dworzynski et al, 2014;Villamañán et al, 2011). These problems can be either underdiagnosis (Ferner & McGettigan, 2020)-or overdiagnosis (Ferner & McGettigan, 2020).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

An Action Design Research to Facilitate the Adoption of Personal Health Records

Ngassam

Ung

Ologeanu-Taddeï

et al. 2021

Journal of Organizational and End User Computing

View full text Add to dashboard Cite

Adoption and user perceptions are dominant on personal health records literature and have led to a better understanding of what individuals' behaviors and perceptions are about the adoption of personal health records. However, these insights are descriptive and are not actionable to allow creating personal health records that will overcome the adoption problems identified by users. This study uses action design research to provide actionable knowledge regarding user perceptions and adoption and their application in the case of the digital allergy card. To achieve this, we conducted interviews with patients and physicians as part of the evaluation of the digital allergy card mock-up and the first prototype. As results, we provided some research proposals regarding the benefits of, levers for, and barriers to adoption of the digital allergy card that can be tested for several other personal health records.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

An Action Design Research to Facilitate the Adoption of Personal Health Records

Ngassam

Ung

Ologeanu-Taddeï

et al. 2021

Journal of Organizational and End User Computing

View full text Add to dashboard Cite

show abstract

“…Comprehensive documentation of DH is important to prevent accidental re‐exposure to culprit drugs . A European drug allergy passport has been constructed and is strongly recommended by the task force for use after complete allergy workup.…”

Section: Discussionmentioning

confidence: 99%

“…Previous studies demonstrated that many of these prescription errors could be avoided and DHRs could be prevented . Lack of proper DH documentation is the main reason for prescription errors . Therefore, it is necessary to empower the patients as well as medical staff with a more comprehensive DH information and documentation .…”

Section: Discussionmentioning

confidence: 99%

Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper

Brockow

Aberer

Atanasković-Marković

et al. 2016

Allergy

View full text Add to dashboard Cite

The strongest and best‐documented risk factor for drug hypersensitivity (DH) is the history of a previous reaction. Accidental exposures to drugs may lead to severe or even fatal reactions in sensitized patients. Preventable prescription errors are common. They are often due to inadequate medical history or poor risk assessment of recurrence of drug reaction. Proper documentation is essential information for the doctor to make sound therapeutic decision. The European Network on Drug Allergy and Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology have formed a task force and developed a drug allergy passport as well as general guidelines of drug allergy documentation. A drug allergy passport, a drug allergy alert card, a certificate, and a discharge letter after medical evaluation are adequate means to document DH in a patient. They are to be handed to the patient who is advised to carry the documentation at all times especially when away from home. A drug allergy passport should at least contain information on the culprit drug(s) including international nonproprietary name, clinical manifestations including severity, diagnostic measures, potential cross‐reactivity, alternative drugs to prescribe, and where more detailed information can be obtained from the issuer. It should be given to patients only after full allergy workup. In the future, electronic prescription systems with alert functions will become more common and should include the same information as in paper‐based documentation.

show abstract